Please assess the completion status of the following clinical trial:

Trial Title: Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 10.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically confirmed acute lymphoblastic leukemia (ALL)~* No secondary ALL~PATIENT CHARACTERISTICS:~* No prior disease that would preclude treatment with chemotherapy~PRIOR CONCURRENT THERAPY:~* More than 4 weeks since prior chemotherapy~* More than 4 weeks since prior steroids

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Induction Prot I/Dexa - reinduction Prot III (Type: EXPERIMENTAL): None
- Induction Prot I/Pred - reinduction Prot III (Type: EXPERIMENTAL): None
- Induction Prot I/Dexa - reinduction Prot II (Type: EXPERIMENTAL): None
- Induction Prot I/Pred - reinduction Prot II (Type: ACTIVE_COMPARATOR): None
- Induction Prot I/Dexa - reinduction 2x Prot III (Type: EXPERIMENTAL): None
- Induction Prot I/Pred - reinduction 2x Prot III (Type: EXPERIMENTAL): None
- Induction Prot I/Dexa - reinduction 3 HR courses + 3x Prot III (Type: EXPERIMENTAL): None
- Induction Prot I/Pred - reinduction 3 HR courses + 3x Prot III (Type: EXPERIMENTAL): None
- Induction Prot I/Dexa - reinduction 6 HR courses + Prot II (Type: EXPERIMENTAL): None
- Induction Prot I/Pred - reinduction 6 HR courses + Prot II (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).